|
[1]
|
Chamot, A.M., Benhamou, C.L., Kahn, M.F., et al. (1987) Acne-Pustulosis-Hyperostosis-Osteitis Syndrome. Results of a National Survey. 85 Cases. Revue du Rhumatisme et des Maladies Osteo-Articulaires, 54, 187-196.
|
|
[2]
|
Duan, N., Chen, X., Liu, Y., et al. (2016) Multimodal Imaging Findings of SAPHO Syndrome with No Skin Lesions: A Report of Three Cases and Review of the Literature. Experimental and Therapeutic Medicine, 12, 2665-2670. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Colina, M., Govoni, M., Orzincolo, C., et al. (2009) Clinical and Ra-diologic Evolution of Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome: A Single Center Study of a Cohort of 71 Subjects. Arthritis and Rheumatism, 61, 813-821. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Schilling, F. and Kessler, S. (2000) SAPHO Syndrome: Clinico-Rheumatologic and Radiologic Differentiation and Classification of a Patient Sample of 86 Cases. Zeitschrift fur Rheumatologie, 59, 1-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Govoni, M., Colina, M., Massara, A., et al. (2009) SAPHO Syn-drome and Infections. Autoimmunity Reviews, 8, 256-259. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Przepiera-Będzak, H. and Brzosko, M. (2018) Clinical Symptoms, Imaging, and Treatment of SAPHO Syndrome: A Single-Center Study of 52 Cases. Polish Archives of Internal Medicine, 128, 396-399. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Li, C., Xiang, Y., Wu, X., et al. (2020) Serum IgG4 Elevation in SAPHO Syndrome: Does It Unmask a Disease Activity Marker? Clinical and Experimental Rheumatology, 38, 35-41.
|
|
[8]
|
Jansson, A., Renner, E.D., Ramser, J., et al. (2007) Classification of Non-Bacterial Osteitis: Retrospective Study of Clinical, Immunological and Genetic Aspects in 89 Patients. Rheumatology (Oxford, England), 46, 154-160. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Przepiera-Będzak, H., Fischer, K. and Brzosko, M. (2015) Se-rum IL-6 and IL-23 Levels and Their Correlation with Angiogenic Cytokines and Disease Activity in Ankylosing Spondylitis, Psoriatic Arthritis, and SAPHO Syndrome. Mediators of Inflammation, 2015, Article ID: 785705. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hurtado-Nedelec, M., Chollet-Martin, S., Nicaise-Roland, P., et al. (2008) Characterization of the Immune Response in the Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO) Syndrome. Rheumatology (Oxford, England), 47, 1160-1167. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Li, C., Zuo, Y., Wu, N., et al. (2016) Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis Syndrome: A Single Centre Study of a Cohort of 164 Patients. Rheumatology (Oxford, England), 55, 1023-1030. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Przepiera-Będzak, H. and Brzosko, M. (2021) SAPHO Syn-drome: Pathogenesis, Clinical Presentation, Imaging, Comorbidities and Treatment: A Review. Postępy Dermatologii i Alergologii, 38, 937-492. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Malara, G., Verduci, C., Altomonte, M., et al. (2022) Thalidomide and Discoid Lupus Erythematosus: Case Series and Review of Literature. Drugs in Context, 11. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Calderon, P., Anzilotti, M. and Phelps, R. (1997) Thalidomide in Der-matology. New Indications for an Old Drug. International Journal of Dermatology, 36, 881-887. [Google Scholar] [CrossRef] [PubMed]
|